Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy

BACKGROUND: Interstitial brachytherapy for localised prostate cancer may be followed by transient increases in prostate-specific antigen (PSA) that resolve without therapy. Such PSA bounces may be associated with an improved outcome but often cause alarm in the patient and physician, and have defied...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yoichiro, Offord, Chetan P, Kimura, Go, Kuribayashi, Shigehiko, Takeda, Hayato, Tsuchiya, Shinichi, Shimojo, Hisashi, Kanno, Hiroyuki, Bozic, Ivana, Nowak, Martin A, Bajzer, Željko, Dingli, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947697/
https://www.ncbi.nlm.nih.gov/pubmed/27404586
http://dx.doi.org/10.1038/bjc.2016.171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947697/
https://www.ncbi.nlm.nih.gov/pubmed/27404586
http://dx.doi.org/10.1038/bjc.2016.171

Ejemplares similares